tiprankstipranks
Advertisement
Advertisement
Racura Oncology gains ethics approval to expand HARNESS-1 lung cancer trial
PremiumCompany AnnouncementsRacura Oncology gains ethics approval to expand HARNESS-1 lung cancer trial
1M ago
Race Oncology Options Expire Unexercised, Trimming Potential Dilution
Premium
Company Announcements
Race Oncology Options Expire Unexercised, Trimming Potential Dilution
1M ago
Racura Oncology Begins Dosing in Phase 1 HARNESS-1 Lung Cancer Trial
Premium
Company Announcements
Racura Oncology Begins Dosing in Phase 1 HARNESS-1 Lung Cancer Trial
1M ago
Racura Raises $24.4m as 97% of Piggyback Options Are Exercised
PremiumCompany AnnouncementsRacura Raises $24.4m as 97% of Piggyback Options Are Exercised
2M ago
Racura Oncology Options Lapse, Trimming Potential Equity Dilution
Premium
Company Announcements
Racura Oncology Options Lapse, Trimming Potential Equity Dilution
2M ago
Racura Oncology Raises $31.2m as Specialist Investor Takes Strategic Stake
Premium
Company Announcements
Racura Oncology Raises $31.2m as Specialist Investor Takes Strategic Stake
2M ago
Racura Oncology director boosts stake with $500,000 option exercise
PremiumCompany AnnouncementsRacura Oncology director boosts stake with $500,000 option exercise
2M ago
Racura Oncology Seeks ASX Quotation for 1.5 Million New Shares
Premium
Company Announcements
Racura Oncology Seeks ASX Quotation for 1.5 Million New Shares
2M ago
Racura Oncology Director Boosts Stake With $500,000 Option Exercise
Premium
Company Announcements
Racura Oncology Director Boosts Stake With $500,000 Option Exercise
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100